SHP2 is also widely expressed in hematopoietic cells, including both lymphoid and myeloid cells, and there is emerging evidence to support its role in tumor immunity (Liu et al., 2017; Liu et al., 2020; Quintana et al., 2020; Wang et al., 2021). The gene discussed is PTPN11; the disease is neoplasm.